Abstract
Purpose
To evaluate the role of combination of N-acetylcysteine with stepwise ram** voltage in renal protection against the ischemic, vascular and oxidative effects of extracorporeal shock wave lithotripsy.
Patients and methods
A prospective randomized trial on 164 adult patients scheduled for ESWL for single renal stones. Patients with radio-lucent stones, diabetes, hypertension, febrile UTI, and preoperative albuminuria were excluded from the study. Patients were randomized into one of four groups. Group A patients received maximal fixed voltage of ESWL. Group B patients received stepwise ram** voltage of ESWL. Group C patients received fixed maximal voltage with N-acetylcysteine (NAC) 600 mg/bid from 48 h before to 24 h after the procedure. Group D patients received gradual ram** voltage with NAC. Urinary β2-microglobulin, 24 h albumin and N-acetyl-β-d-glucosaminidase/creatinine ratio at 1 day and 5 days post-ESWL and the stone free rate at 2 weeks were measured.
Results
Group D was the only group that showed no significant difference pre and post ESWL in urinary albumin, β2-microglobulin and N-acetyl-β-d-glucosaminidase/creatinine ratio. Post hoc analysis revealed no significant difference between group B and group C in albumin, β2-microglobulin N-acetyl-β-d-glucosaminidase/creatinine ratio, but both of them had significantly lower levels than group A and significantly higher levels than group D. There was no statistically significant difference between all groups in the stone free rate at 2 weeks.
Conclusion
N-acetylcysteine protects the kidney against ESWL-induced renal injuries especially if combined with stepwise ram** voltage.
Similar content being viewed by others
References
Khan A (2018) Prevalence, pathophysiological mechanisms and factors affecting urolithiasis. Int Urol Nephrol 50(5):799–806
Drach GW, Dretler SW, Fair W, Finlayson B, Gillenwater J, Griffith D, Lingeman J, Newman D (1986) Report of the United States cooperative study of extracorporeal shock wave lithotripsy. J Urol 135:1127–1131
Turk C, Knoll T, Petrik A, Skolarikos A, Neisius A, Seitz C, Thomas K (2020) Urolithiasis, EAU guidelines. http://uroweb.org/guideline/urolithiasis/. Accessed Dec 2020
El-Nahas AR, Elsaadany MM, Diaa-Eldin T, Elshal AM, Abo El-Ghar M, Amani MI, Elsawy E, Hazem HS, Wafa E, Amira A, Barakat TS, Sheir KZ (2017) A randomised controlled trial evaluating renal protective effects of selenium with vitamins A, C, E, verapamil, and losartan against extracorporeal shockwave lithotripsy-induced renal injury. BJU Int 119:142–147
Karlsen SJ, Smevik B, Stenstrom J, Berg KJ (1990) Acute physiological changes in canine kidneys following exposure to extracorporeal shock waves. J Urol 143:1280–1283
Vicente MK, Djalma JF, Cesar OP, Oskar K, Anna TN, Valdemar O (2008) Effects of repeated extracorporeal shock wave on kidney apoptosis of normal and diabetic rat. Int Braz J Urol 34:91–96
McAteer JA, Andrew PE (2008) The acute and long-term adverse effects of shock wave lithotripsy. Semin Nephrol 28(2):200–213
Kerbl K, Rehman J, Landman J, Lee D, Sundaram C, Clayman RV (2002) Current management of urolithiasis: progress or regress? J Endourol 16:281–288
Bolignano D, Donato V, Coppolino G, Campo S (2008) Neutrophil gelatinase associated lipocalin (NGAL) as a marker of kidney damage. Am J Kid Dis 52:595–605
Delvecchio F, Auge BK, Munver R (2003) Shock wave lithotripsy causes ipsilateral renal injury remote from the focal point: the role of regional vasoconstriction. J Urol 169:1526–1529
So Ra K, Yong-ho L, Sang-Guk L, Eun SK, Bong-Soo C, Jeong-Ho K, Byung-Wan L (2016) Urinary N-acetyl-b-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes. Med. 95(27):1–8
Honey RJ, Ray AA, Ghiculete D (2010) Shock wave lithotripsy: a randomized, double-blind trial to compare immediate versus delayed voltage escalation. J Urol 75:38–43
Kim J, Jang HS, Park KM (2010) Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice. Am J Renal Physiol 298(1):158–166
Mazzon E, Britti D, De Sarro A, Caputi AP, Cuzzocrea S (2001) Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol 424:75–83
Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude FJ (2003) Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362:598–603
El-Assmy A, Harraz A, Eldemerdash Y, Elkhamesy M, El-Nahas A, Elshal A, Sheir K (2016) Does lithotripsy increase stone recurrence? A comparative study between extracorporeal shockwave lithotripsy and non-fragmenting percutaneous nephrolithotomy. Arab J Urol 14(2):108–114
Skuginna V, Nguyen DP, Seiler R, Kiss B, Thalmann GN, Roth B (2016) Does stepwise voltage ram** protect the kidney from injury during extracorporeal shockwave lithotripsy? Results of a prospective randomized trial. Eur Urol 69:267–273
Kehinde EO, Al-Awadi KA, Al-Hunayan A (2008) Antioxidant therapy is associated with a reduction in the serum levels of mediators of renal injury following lithotripsy for renal calculi. J Endourol 22:2537–2545
Li BL, Weizheng Z, Puyun L (1995) Protective effects of nifedipine and allopurinol on high energy shock wave induced acute changes of renal function. J Urol 153:596–598
Strohmaier WL, Bichler KH, Koch J, Balk N, Wilbert DM (1993) Protective effect of verapamil on shock wave induced renal tubular dysfunction. J Urol 150:27–29
Ogiste JS, Nejat RJ, Rashid HH, Greene T, Gupta M (2003) The role of mannitol in alleviating renal injury during extracorporeal shock waves lithotripsy. J Urol 169:875–877
Connors BA, Evan AP, Blomgren PM, Handa RK, Willis LR, Gao S (2009) Effect of initial shock wave voltage on shock wave lithotripsy-induced lesion size during step-wise voltage ram**. BJU Int 103(1):104–107
Demirci D, Mustafa S, Yalcin E, Ekmekcioglu O, Gulmez I, Karacagil M (2007) Comparison of conventional and step-wise shockwave lithotripsy in management of urinary calculi. J Endourol 21:1407–1410
Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343(3):180–184
Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER (2004) Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 117:938–947
Renfan XU, Anyu T, Yang B, Youbin D, Guangzhi C (2016) Effectiveness of N-acetylcysteine for the prevention of contrast-induced nephropathy: asystematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 5(9):1–31
Wen-Qi M, Zhao Y, Wang Y, **-Qiong H, Zhu Y, Nai-Feng L (2018) Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials. Int Urol Nephrol 50(6):1085–1095
Erturk M, Uslu N, Gorgulu S, Akbay E, Kurtulus G, Akturk IF, Akgul O, Surgit O, Uzun F, Gul M, Isiksacan N, Yildirim A (2014) Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin c? J Coron Artery Dis 25:111–117
Ceylan B, Ozansoy M, Kilic U, Yozgat Y, Ercan C, Yildiz P, Aslan T (2018) N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions. Ren Fail 40(1):423–434
Chi-Fai N, Chi Hang Y, Jeremy YC, Becky L, Steven CH, Christine YP, Wong KT, Winnie CW, John Y (2019) Effect of stepwise voltage escalation on treatment outcomes following extracorporeal shock wave lithotripsy of renal calculi: a prospective randomized study. J Urol 201(5):1121–1126
Al-Awadi KA, Kehinde EO, Loutfi I, Mojiminiyi OA, Al-Hunayan A, Abdul-Halim H, Al-Sarraf A, Memon A, Abraham MP (2008) Treatment of renal calculi by lithotripsy: minimizing short-term shock wave induced renal damage by using antioxidants. Urol Res 36(1):51–60
Christian G, Hans-Goran T (2018) How can and should we optimize extracorporeal shockwave lithotripsy? Urolithiasis 46:3–17
Armaly Z, Artol S, Jabbour A, Saffouri A, Habashi N, Abd Elkadir A, Ghattas N, Farah R, Kinaneh S, Nseir W (2019) Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients. Ren Fail 41(1):976–986
Mehmet NM, Yakup B, Ender Ö, Şaban S (2019) Protective effects of oral sirolimus therapy against ESWL-induced kidney tissue damage in rats. J Urol Surg 6(3):190–195
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no relevant financial interests or conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Desoky, E.A.E., Sakr, A.M., Alhefnawy, M. et al. Renal protective effect of N-acetylcysteine with stepwise ram** voltage against extracorporeal shock wave lithotripsy-induced renal injury: a prospective randomized trial. Int Urol Nephrol 52, 2261–2267 (2020). https://doi.org/10.1007/s11255-020-02580-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02580-1